These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 27695310)

  • 21. Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain ("The ESPIRAL-ES Study").
    Trigueros JA; Riesco JA; Alcázar-Navarrete B; Campuzano A; Pérez J
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2469-2478. PubMed ID: 31806956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between markers of emphysema and more severe chronic obstructive pulmonary disease.
    Boschetto P; Quintavalle S; Zeni E; Leprotti S; Potena A; Ballerin L; Papi A; Palladini G; Luisetti M; Annovazzi L; Iadarola P; De Rosa E; Fabbri LM; Mapp CE
    Thorax; 2006 Dec; 61(12):1037-42. PubMed ID: 16769715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The extent of emphysema in patients with COPD.
    Shaker SB; Stavngaard T; Hestad M; Bach KS; Tonnesen P; Dirksen A
    Clin Respir J; 2009 Jan; 3(1):15-21. PubMed ID: 20298367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of inspiratory capacity on dyspnea evaluation in COPD with or without emphysematous lesions: a pilot study.
    Cui L; Ji X; Xie M; Dou S; Wang W; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2823-2830. PubMed ID: 29033563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality in COPD patients according to clinical phenotypes.
    Golpe R; Suárez-Valor M; Martín-Robles I; Sanjuán-López P; Cano-Jiménez E; Castro-Añón O; Pérez de Llano LA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1433-1439. PubMed ID: 29750029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emphysema presence, severity, and distribution has little impact on the clinical presentation of a cohort of patients with mild to moderate COPD.
    de Torres JP; Bastarrika G; Zagaceta J; Sáiz-Mendiguren R; Alcaide AB; Seijo LM; Montes U; Campo A; Zulueta JJ
    Chest; 2011 Jan; 139(1):36-42. PubMed ID: 20705800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease.
    French A; Balfe D; Mirocha JM; Falk JA; Mosenifar Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1305-12. PubMed ID: 26203237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study".
    Alcázar-Navarrete B; Trigueros JA; Riesco JA; Campuzano A; Pérez J
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1115-1124. PubMed ID: 29692606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome.
    Xie M; Wang W; Dou S; Cui L; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():953-61. PubMed ID: 27226711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations.
    Cheng Y; Tu X; Pan L; Lu S; Xing M; Li L; Chen X
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2069-2074. PubMed ID: 28790809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predominant emphysema phenotype in chronic obstructive pulmonary.
    Boschetto P; Miniati M; Miotto D; Braccioni F; De Rosa E; Bononi I; Papi A; Saetta M; Fabbri LM; Mapp CE
    Eur Respir J; 2003 Mar; 21(3):450-4. PubMed ID: 12662000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema.
    Löfdahl JM; Cederlund K; Nathell L; Eklund A; Sköld CM
    Eur Respir J; 2005 Feb; 25(2):275-81. PubMed ID: 15684291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used.
    Jögi J; Markstad H; Tufvesson E; Bjermer L; Bajc M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():25-30. PubMed ID: 25565797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
    Echave-Sustaeta JM; Comeche Casanova L; Cosio BG; Soler-Cataluña JJ; Garcia-Lujan R; Ribera X
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1307-14. PubMed ID: 25429213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Which pulmonary function tests best differentiate between COPD phenotypes?
    Salzman SH
    Respir Care; 2012 Jan; 57(1):50-57; discussion 58-60. PubMed ID: 22222125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative prevalence of co-morbidities in smoking and non-smoking asthma patients with incomplete reversibility of airway obstruction, non-smoking asthma patients with complete reversibility of airway obstruction and COPD patients.
    Nadeau M; Boulay MÈ; Milot J; Lepage J; Bilodeau L; Maltais F; Boulet LP
    Respir Med; 2017 Apr; 125():82-88. PubMed ID: 28340867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.
    Jeong SH; Lee H; Carriere KC; Shin SH; Moon SM; Jeong BH; Koh WJ; Park HY
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1857-65. PubMed ID: 27536097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbidities and COPD severity in a clinic-based cohort.
    Raherison C; Ouaalaya EH; Bernady A; Casteigt J; Nocent-Eijnani C; Falque L; Le Guillou F; Nguyen L; Ozier A; Molimard M
    BMC Pulm Med; 2018 Jul; 18(1):117. PubMed ID: 30012144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.